Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Michael H. Serrano‐Wu, Cornelia J. Forster et al.|Journal of Medicinal Chemistry|2017Cited by 18
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKatsumasa Nakajima, Bing Wang, Myriam April et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 5
A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoung‐Shin Kwak, Michael H. Serrano‐Wu, Gary M. Coppola et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 3